FDA urged to reverse policy

Patients, Doctors, Pharmacists Praise Bipartisan House Resolution On Compounded Hormones Containing Estriol

The International Academy of Compounding Pharmacists joined hundreds of thousands of women and doctors in applauding the introduction of H. Con. Res. 342, a bipartisan resolution stating that “the Food and Drug Administration’s (FDA) new policy restricting women’s access to medications containing estriol does not serve the public interest” and calling on the FDA to “reverse its policy.”

Reps. Mike Ross (D-Ark.), Jo Ann Emerson (R-Mo.), Sam Farr (D-Calif.), Tammy Baldwin (D-Wisc.), Michael Burgess (R-Texas), John Carter (R-Texas) and Gabrielle Giffords (D-Ariz.) introduced the resolution in the House of Representatives.

More:http://www.medicalnewstoday.com/articles/106784.php